Join the life science list by selecting the image on the left, or join multiple lists by completing the form on the right.
Groups include: clean energy, high tech, life science, virtual worlds, women leaders, and executives.
FountainBlue stimulates collaborative innovation, one
conversation, one leader, one organization at a time through our monthly
events, our dynamic communities, our ongoing discussions on entrepreneurial
issues, our invitation-only CEO forums, and through our consulting services.
FountainBlues
Life Science Entrepreneurs Forums were launched in September 2006 and have
continued to grow and become an exceptionally high value entrepreneur event in
Silicon Valley. These events routinely attract between 40 to more than 100 life
science entrepreneurs, intrapreneurs and investors each month. The topics cover
the range of early stage entrepreneurship challenges and opportunities. An
invitation to this months event is below, along with a calendar of past and
upcoming topics and speakers, and notes from all our previous sessions are
available at http://fountainblue.biz/cleanenergy/cleanenergynotes.html.
Our
events are typically held on the third Mondays of the month (or fourth Mondays
in January and February) from 5:30 until 7:30 p.m., and include networking and
registration for the first half hour, fast pitches from three entrepreneurs to
start off the event, and a panel discussion, with half an hour reserved at the
end for Q&A. Testimonials are available below as well. If you are an
entrepreneur, intrapreneur or investor, we invite you to sign up for our free
mailing list using the form above. We hope to see you at an event soon. (Please
note that this event is not for service providers.)
We welcome your continued participation and input and hope to
connect with you soon.
Join our community on BigTent by visiting https://www.bigtent.com/groups/fountainblue See the list of upcoming events for the month and register to
attend one soon! Sign up for our free newsletter by completing the form above If you are an early stage entrepreneur and would like to discuss
your new venture, suggest some office hours on Mondays, Wednesdays or Fridays
between 8:30 a.m. and 1:00 p.m. Peruse our web site to find out more about FountainBlue and all
our activities
Send us an e-mail to tell us how we can best serve you! info@svlifescience.com
FountainBlue's Life Science Entrepreneurs' Forum
Topic: International
Challenges and Opportunities for Life Science Companies
Date & Time: Monday,
March 15 from 5:30 - 7:30 p.m.
Pre-register:$21
members, $32 partners, $42 general
Late and On-Site Cost: $42 members, $52 non-members, $124
Ongoing membership and admission
Registration: Please
pre-register by noon on 3/12 using the adjacent PayPal link
Audience: Life
Science entrepreneurs, intrapreneurs and investors, no service providers please
International
Challenges and Opportunities for Life Science Companies
Resilient, resourceful, life science entrepreneurs are
advancing their businesses, and developing international programs and
relationships to better advance their technology, provide clinical research,
and serve their markets. For this panel, life science entrepreneurs,
intrapreneurs and investors on what’s working and what’s not in different
international markets. This month’s panel will feature:
Facilitator John Bashkin, Vice President, Strategic Business Development, Triple Ring
Technologies
Panelist William Goure,
President and Chief Executive Officer, Acumen Pharmaceuticals
Panelist Taylor Kilfoil,
President and CEO, InClin, Inc.
Panelist Evgeny Zaytsev,
General Partner, Helix Ventures
Panelist from Morrison Foerster
to be confirmed
Pre-register for our upcoming FountainBlue life science event. Note that registrations must be time-stamped by noon on the business day prior to the event, generally Fridays for events to be held on Mondays.
As a member, you are welcome to pre-register for any other upcoming FountainBlue event as well. Note that registrations must be time-stamped by noon on the business day prior to the event. Registrations arriving after that deadline will be applied to NEXT MONTH's event.
Panelist Bios
Facilitator John
Bashkin, Vice President, Strategic Business Development
Dr. John Bashkin has 18 years of experience in technology, product,
and business development for life sciences and medical devices. He has held
senior business development positions at SRI International and, most recently,
at Artificial Muscle, Inc.
While at SRI for seven years, Dr. Bashkin headed up business
development efforts for life science and medical device technologies from
across the institute as well as led his own NIH-funded research programs and
served on the IP Committee for the Institute. He led contract and out-licensing
negotiations for many technology and product development programs.
At Artificial Muscle, he was responsible for all corporate contract
matters as well as business development for the medical industry. Prior to
joining SRI, Dr. Bashkin was a senior researcher at Molecular Dynamics and
Amersham, where he led the development of the first high-throughput DNA
sequencing system.
He received his B.S. in Chemistry and Physics from the University of
Arizona, his Ph.D. in Chemistry from Indiana University, and held post-doc
positions at the University of Rochester and Johns Hopkins University. In 2000,
he received his MBA from Santa Clara University.
Dr. Bashkin is a co-inventor on five issued U.S. patents and co-author
on more than 20 publications.
Panelist Taylor
Kilfoil, President, CEO and Co-Founder, Inclin, Inc.
Taylor Kilfoil is the President, CEO and Co-Founder of Inclin, which provides
a range of clinical, regulatory, and quality assurance services to
pharmaceutical, biotechnology, and medical device companies. Taylor earned a
Bachelor of Science from St. John’s University.
Panelist Dr. William Goure, President and CEO,
Acumen Pharmaceuticals
Since May 2008,
Dr. Goure has been President and CEO for Acumen Pharmaceuticals. Dr.
Goure has over 20 years of domestic and international experience in the
discovery, development, registration, commercial development, and
commercialization of chemical and biotechnology products.
Prior to joining
Acumen, Dr. Goure was Vice-President for Commercial Development for Mendel
Biotechnology, a bay area company dedicated to creating value through the
discovery, development and commercialization of knowledge about plant gene
expression. At Mendel, Dr. Goure negotiated numerous technology
collaboration and partnership agreements that generated over $29 million
dollars of near term revenues.
Prior to joining
Mendel, Dr. Goure worked for Monsanto Company for 17 years where he developed
and commercialized Roundup Ready® soybeans, canola, and cotton. Dr. Goure
was a member of the team that established Monsanto’s quality traits program
that led to the Renessen joint (partnership) with Cargill, and was responsible
for establishing commercial launch teams in Eastern Europe, South Africa, and
Southern Latin America.
Dr. Goure has a
B.S. degree in Chemistry from Fort Lewis College, Durango Colorado, and a Ph.D.
degree in organic chemistry from Iowa State University. Prior to joining
Monsanto, Dr. Goure was a Post-Doctoral Fellow at Colorado State University.
Panelist Dr. Evgeny Zaytsev, General
Partner, Helix Ventures
Evgeny Zaytsev co-founded Helix Ventures in 2008 and brings eight years of
venture capital and nine years of operations and research experience to the
firm. Since 2001 together with Graham Crooke he managed the life sciences
portfolio in two venture capital partnerships at Asset Management Company, one
of the oldest venture capital firms in Silicon Valley. He was one of the key
executives of the Medico-Ecological Institute, a research institute established
in Russia in 1993 to study the health and environmental effects of the Soviet
Union’s nuclear testing program. An expert in physiology and radiation biology,
he was chief scientific officer from 1994 to 2000 and during his tenure the
institute became an internationally recognized research center. He is the
author or co-author of 45 scientific and business publications, including six
books on radiation and cancer epidemiology. From 1991 to 2000, he was also an
assistant professor in physiology at the Altai State Medical University in
Barnaul, Siberia.
He received his M.D. (cum laude) in 1991 and his Ph.D. in physiology in 1993,
both from the Altai State Medical University. He earned his M.B.A. from the
Stanford Graduate School of Business in 2002. He is currently a director of
several private life sciences companies. He is an Advisory Board member and
past president of the American Business Association of Russian Professionals.
Panelist from Morrison Foerster to be
confirmed
Below is our calendar for our 2010 life science entrepreneurs' forums. We invite your participation as part of the program committee and we invite your nominations for entrepreneurs, intrapreneurs or investors to join our panels.
Date
Title
Speakers
Description
Monday,
January 25 at KPMG 500 E. Middlefield Road in
Mountain View
Panelist Anne DeGheest, Founder and Managing
Director, MedStars, Strategic Advisor at PolyRemedy, Inc
Panelist Stuart Eckmann, Keiretsu Forum and Life
Science Angels
Panelist Don Ross, Member, Life Science Angels and
Sand Hill Angels
Panelist Michael Weickert, President and CEO, S.E.A.
Medical Systems, Inc., Member, Life Science Angels, Venture Partner,
Kranenburg Fund
Life
science angel investors are generally seasoned executives with deep strategic
and operational experience in running successful life science businesses,
from concept to clinical trials to regulatory approvals, manufacturing and
distribution. They generally also have extensive experience within
corporations in various roles, and continue to develop these partnerships as
they support their portfolio companies.
The
life science angel investors panelists have been seen a wide range of life
science business models, and have their own thoughts and recommendations on how
to be successful in these challenging times. Topics will include how early
stage companies can position themselves for successful partnerships and
fundings, strategically plan your business based on evolving market needs,
tightly manage cash flow, and build strategic alliances with larger
organizations, angels, research organizations, and other key stakeholders.
As part
of this month’s program, we will solicit feedback from all our attendees on
the challenges and opportunities in through facilitated small groups, based
on life science sub-industry topics: Software solutions for the healthcare
industry, medical devices, personalized medicine, medical imaging, and
biopharma.
Monday,
February 22 @ Bay Café Clubhouse, 1875 Embarcadero, Palo Alto
What's Funded, What's Hot, What's Next, Projections for
2010
Facilitator
from KPMG to be confirmed
VC to
be confirmed
Investment
Banker to be confirmed
Corporate
Investor to be confirmed
Panelist
Zachary Antovich, President and CEO, Linkage Biosciences Inc
Show Me
the Money: Resourceful Ways to Secure Funding for YOUR Life Science Company
in THIS Economy
even if
the economic projections are getting more rosy, ask anyone running an early
stage company and they will tell you that times are tough out there! The life
science industry has provided a ray of hope when the economy was at its
darkest.
Historically
known as a slow-moving industry, it has also been more resilient and less
impacted by the recent economic challenges. This month, we will feature a
panel of seasoned entrepreneurs and investors who will share their thoughts
and suggestions on how to secure funding for life science start-ups, from
grant and government funding to angel, venture and corporate funding. They
will share their recent success stories and help you brainstorm how to best
position your company financing.
Panelist
from Altera to be confirmed
Panelist from Boston Scientific to be confirmed
Panelist from Agilent to be confirmed
Panelist from Varian to be confirmed
Panelist
VC with international offices
Presenting
Entrepreneur (with Asian ties)
Presenting
Entrepreneur (with ties in Europe)
Resilient,
resourceful, life science entrepreneurs are advancing their businesses, and
developing international programs and relationships to better advance their
technology, provide clinical research, and serve their markets. For this
panel, life science entrepreneurs, intrapreneurs and investors on what’s
working and what’s not in different international markets.
Monday,
April 19 @ Intuitive Surgical 1266 Kifer Road, Building 101
Sunnyvale
Facilitator
from Stanford University to be confirmed
PanelistUrological Surgeon
Panelist
from Kaiser to be confirmed
Panelist
from El Camino Hospital to be confirmed
Panelist
from Intuitive Surgical to be confirmed
Panelist
Anesthesiologist to be confirmed
Panelist
OBGYN to be confirmed
Panelist
from policy to be confirmed
Presenting
Entrepreneurs to be confirmed
Experienced
executives and entrepreneurs find resourceful ways to continue their R&D,
even in the best of economic conditions, but especially during a downturn
when there are so many cost-effective resources and opportunities for new
products and markets with the return to economic stability. This month, we
will convene corporate intrapreneurs who share their R&D strategies, and
their thoughts on which markets will be hot.
Sponsor
Facilitator to be confirmed
Panelist from Triple Ring Technologies to be confirmed
Panelist from LifeScan to be confirmed
Panelist from CardioDX to be confirmed
Panelist from Applied Biosystems, a Life Technologies Company, to be
confirmed
Panelist from Boston Scientific, to be confirmed
Presenting Entrepreneurs to be confirmed
Success
in today's life science regulatory environment requires balancing the management
and impact of federal, state and local policies on the rapid pace of
technology development and science advancement in today's life science
businesses. This month's seasoned life science specialists will share their
perspectives on the impact and interplay of regulatory requirements on
reimbursement, technology development, science exploration and other business
functions for life science entrepreneurs, intrapreneurs and investors.
Sponsor
Facilitator to be confirmed
Panelist VC to be confirmed
Panelist Pre-funded Entrepreneur to be confirmed
Panelist Seed-funded Entrepreneur to be confirmed
Panelist Series A funded Entrepreneur to be confirmed
Panelist Series B/C-funded Entrepreneur to be confirmed
Even
when times were flush, it was difficult for life science entrepreneurs and
execs to develop a comprehensive strategy that could be well executed. The
additional challenges of regulatory, clinical trials, manufacturing,
distribution, etc., add to the normal business challenges of people,
technology and markets. Yet, no matter what the circumstances, resourceful
entrepreneurs, intrapreneurs and investors find a way to make it work. This
month's panel will share the creative strategies that are working for them,
and the additional work they need to do to navigate today's challenging
business environment.
Sponsor
Facilitator tbd
Panelist from Triple Ring Technologies, to be confirmed
Panelist Ted Spack, Managing Director, Fast Forward LLC, to be confirmed
Panelist from San Jose Biocenter, to be confirmed
Panelist from Stanford, to be confirmed
Panelist from Applied Biosystems, a Life Technologies Company, to be
confirmed
Early
stage life science just take longer to develop, longer to bring to market.
Resourceful entrepreneurs are learning to partner with incubators and
researchers and corporations to bring technologies from out of the labs and
into the market. This month's life science entrepreneurs' forum will
highlight strategies on how best to partner with corporations and incubators
and researchers, and collaboratively bring cutting edge life science
technologies to the market.
Monday,
September 27 @ Altera 101 Innovation Drive in San Jose
Sponsor Facilitator to be confirmed
Panelist VC to be confirmed
Panelist from Intuitive Surgical to be confirmed
Panelist from Altera to be confirmed
Panelist from Stanford to be confirmed
Panelist from Boston Scientific, to be confirmed
Presenting Entrepreneurs to be confirmed
This
month we will highlight successful medical device solutions from implantables
to clinical equipment and also cover partnering across academia and industry
to advance the industry, and the future of medical device industry in
general.
Sponsor Facilitator to be confirmed
Panelist VC to be confirmed
Panelist from Intuitive Surgical to be confirmed
Panelist from Altera to be confirmed
Panelist from Affymetrix to be confirmed Panelist
from Applied Biosystems, a Life Technologies Company, to be confirmed
Presenting Entrepreneurs to be confirmed
This
month we examine the convergence of technology and health care, and profile
software solutions which benefit health service professionals, from health IT
platforms to pharmaceutical tracking, health monitoring and more.
Facilitator
tbd
Panelist from Applied Biosystems, part of Life Technologies, to be confirmed
Panelist VC, tbd
Panelist from Stanford, tbd
Panelist from Nektar TBD
Presenting Entrepreneur tbd
Presenting Entrepreneur tbd
Presenting Entrepreneur tbd
The
accelerated pace of technology advancements is opening up new offerings in
personalized medicine, in biomarker training, in Invitro diagnostics. This
month we feature groundbreaking leaders to showcase advances and
opportunities in this market and touch upon cultural and moral dilemmas which
arise as these offerings gain traction.
Monday,
December 20
Holiday Break
n/a
Please join us in thanking our facilitators, speakers, and sponsors for FountainBlue's 2009 life science events.
• Angel Panelists:
o Stuart Eckmann, Keiretsu Forum and Life Science Angels (Bio and Device
Committees)
o Elaine Heron, Life Science Angels and LabCyte
o Anne DeGheest, MedStars
o Don Ross, Life Science Angels and Sand Hill Angels
• Featured Recently-Funded Entrepreneurs:
o Mitchell Mutz, CSO, Amplyx Pharmaceuticals
o Michelle Stecklein Call, CEO, Lypro BioScience
Life
science angel investors are generally seasoned executives with deep strategic
and operational experience in running successful life science businesses,
from concept to clinical trials to regulatory approvals, manufacturing and
distribution. They generally also have extensive experience within
corporations in various roles, and continue to develop these partnerships as
they support their portfolio companies.
The life science angel investors we’ve recruited for this month’s panel have
been seen a wide range of life science business models, and have their own
thoughts and recommendations on how to be successful in these challenging
times. Topics will include how early stage companies can:
- position themselves for successful partnerships and fundings,
- strategically plan your business based on evolving market needs,
- tightly manage cash flow, and
- build strategic alliances with larger organizations, angels, research
organizations, and other key stakeholders
•
Facilitator Steven Cui, Of Counsel, Jones Day
• Panelist Bonnie Anderson, CEO, Veracyte, Inc.
• Panelist Deborah Kilpatrick, Vice President, Market Development, CardioDx,
Inc.
• Panelist Geetha Rao, Springborne and Molecular Image
• Panelist Mike Richey, Chief Business Officer, Tethys Bioscience
• Panelist David Rollo, President, Cell Point LLC
With
advancements in technology and science, we have not only a greater
understanding of people and their various diseases, but we are also better
understanding the human genome, and are making progress in creating
personalized medicines to customize treatment and even preventive care for
people.
But these advancements are also raising questions: what's the myth, and
what's the science? What's in the research, blue-sky phase, and who is
providing what REAL solutions now? And where's the money in it? What does it
mean for the average person? Our panel will facilitate a discussion covering
these topics and more.
•
Facilitator John Bashkin, Triple Ring Technologies
• Panelist Rob Abrams, Operating Partner, Sanderling Ventures, Former Head of
Business Development, Boston Scientific
• Panelist Dave Scott, Senior Product Manager, Vision Systems, Intuitive
Surgical
• Panelist Niamh Pellegrini, General Manager, LifeScan, a J&J Company
In a
down market, everyone conserves cash, and plans for the future. Experienced
executives and entrepreneurs find resourceful ways to continue their R&D,
especially during a downturn when there are so many cost-effective resources
and opportunities for new products and markets with the return to economic
stability. This month, we will convene corporate intrapreneurs who share
their R&D strategies, and their thoughts on which markets will be hot.
•
Facilitator Myriam Curet, MD, Stanford University, Chief Medical Advisor,
Intuitive Surgical
• Panelist Shahram S. Gholami, M.D., Urological Surgeon
• Panelist Gary Heit, PhD, MD, former Assistant Professor, Director of
Functional Neurosurgery, Dept of Neurosurgery, Kasier Redwood City
• Panelist Frank Lai, MD, Department of Urology, El Camino Hospital
• Panelist Michael Leong, MD, Anesthesiologist
• Panelist James Lilja, PhD, OBGYN
In a
down market, everyone conserves cash, and plans for the future. Experienced
executives and entrepreneurs find resourceful ways to continue their R&D,
especially during a downturn when there are so many cost-effective resources
and opportunities for new products and markets with the return to economic
stability. This month, we will convene corporate intrapreneurs who share their
R&D strategies, and their thoughts on which markets will be hot.
•
Facilitator Joyce Chiarenza, Chiarenza Consulting, L.L.C., Certified Clinical
Compliance Professional, and Instructor, UCSC Extension
• Panelist Walt Cecka, Senior Director, Program Management, Triple Ring
Technologies
• Panelist Krishna Ghosh, VP of Quality and Compliance, Arbor Vita
Corporation
• Panelist Jacques Ginestet, Director, Sustaining Engineering, LifeScan
• Panelist Chris Panarties, Sr. Director, Reimbursement, Health Economics and
Pricing, NeurogesX
• Panelist Susan Rowinski, Sue Rowinski Group LLC, Reimbursement &
Marketing Consulting
Success
in today's life science regulatory environment requires balancing the
management and impact of federal, state and local policies on the rapid pace
of technology development and science advancement in today's life science businesses.
This month's seasoned life science specialists will share their perspectives
on the impact and interplay of regulatory requirements on reimbursement,
technology development, science exploration and other business functions for
life science entrepreneurs, intrapreneurs and investors.
•
Facilitator Dick Haiduck
• Panelist Rich Ferrari, Partner, De Novo Ventures
• Panelist Stevan Jovanovich, CEO, Microchip Biotech
• Panelist Yvonne Linney, VP, Strategy, Marketing and Business Development,
Life Sciences Solutions Unit, Agilent
• Panelist Glen Sato, Partner Cooley Godward Kronish, LLC
• Panelist Charles Versaggi, CEO, OsteoCorp
• Presenting Entrepreneur: Richard Lotti, CEO, Quadra Vascular
• Presenting Entrepreneur: Dr. Sampath Srikanth, DermDx's CEO
• Presenting Entrepreneur: Roger Thomas, CEO, Topavance
Even
when times were flush, it was difficult for life science entrepreneurs and
execs to develop a comprehensive strategy that could be well executed. The
additional challenges of regulatory, clinical trials, manufacturing,
distribution, etc., add to the normal business challenges of people,
technology and markets. Yet, no matter what the circumstances, resourceful
entrepreneurs, intrapreneurs and investors find a way to make it work. This
month's panel will share the creative strategies that are working for them,
and the additional work they need to do to navigate today's challenging
business environment.
•
Facilitator Peter Berger II, CEO, Alitora
• Panelist Ian Irwin, Director of Drug Discovery, Parkinson’s Institute
• Panelist Michael O’Donnell, Partner, Wilson Sonsini
• Panelist Ted Spack, Managing Director, Fast Forward LLC
• Panelist Craig Taylor, Co-Founder and General Partner, Alloy Ventures
• Presenting Entrepreneur: Yadon Arad, Tiara Pharmaceuticals
• Presenting Entrepreneur: Julia O’Connor, CEO, Accelalox Inc.
• Presenting Entrepreneur: David Zarling, CEO, Colby Pharmaceuticals
Life
science professionals are faced with the usual challenges in developing,
testing, manufacturing, approving and distributing biopharma solutions from
drug discovery to therapeutics to enabling platforms. These unique challenges
extend the time from inception to market, yet the companies that successfully
navigate these challenges are companies to watch – bringing financial returns
to companies, and products and services to markets.
With the dramatic and rapid changes in policy and administration and outlook
toward the life science industry overall, new interest has been placed on how
to identify the key players in the biopharma market, and facilitate forward
progress for people and organizations in this industry. This month’s panel
will address today’s unique challenges and share successes worth noting.
• Facilitator Geetha Rao, Springborne Life Sciences
• Panelist Joseph Heanue PhD, President, Triple Ring Technologies
• Panelist Frank Ingle, Senior Research Fellow, Electrophysiology Division,
Boston Scientific
• Panelist Sharbel Noujaim, VP of Product Engineering, LifeScan
• Presenting Evelyn Hu, Chief Marketing Officer and Director of Product
Development, iShoe
• Presenting Tom Moore, President and CEO, Silicon Valley Medical Instruments
• Presenting Michael Weickert, President and CEO at SEA Medical Systems, Inc
Medical
Device Advances: From Implantables to Surgical Tools, From Diagnostics to
Therapeutics
This month we will highlight successful medical device solutions from
implantables to clinical equipment and also cover partnering across academia
and industry to advance the industry, and the future of medical device
industry in general.
Monday,
October 19 @ Intuitive Surgical
Software
Meets Healthcare Services: Health IT Platforms, Pharmaceutical Tracking,
Remote Monitoring and Beyond
•
Facilitator Russell Singleton, President and CEO, Molecular Image
• Panelist Shannon Kelley, Director of Marketing, Intuitive Surgical
• Panelist John Steuart, Claremont Ventures
• Panelist Evgeny Zaytsev, Helix Ventures
• Panelist Steve Douglas, CEO, Data Physics Research
• Presenting Entrepreneur Rohan G.F. Coelho, CEO, Rexanto
• Presenting Entrepreneur Anthony Gioeli, CEO, MedAttune
This
month we examine the convergence of technology and health care, and profile
software solutions which benefit health service professionals, from health IT
platforms to pharmaceutical tracking, health monitoring and more.
•
Facilitator Linda K. Molnar, LKM Strategic Consulting
• Panelist Doug Dolginow, PhD, BOD, Advisor, Founder CSO/CMO, Veracyte, Inc,
and CEO and BOD, NanoValent
• Panelist Kimberlee Caple, Vice President, Genetic Systems Division, Applied
Biosystems, part of Life Technologies Corporation
• Panelist Ted Driscoll, Venture Partner, Claremont Ventures; Active Member,
Life Science Angels; Founding Director, Sand Hill Angels
• Panelist Kendall Wu, Product Manager, Cytogenetics Portfolio, Affymetrix
• Presenting Entrepreneur Richard A. Goozh, Sr. VP, Strategy & Finance,
Wave 80 Biosciences; Managing Director, Cambrian Partners
• Presenting Entrepreneur Dick Haiduck, Partner to the CEO, Implicit
Bioscience and Compugen, advisor to the Queensland Australia government
• Presenting Entrepreneur Massimo Bocchi, Chief Technology Officer, MindSeeds
Laboratories s.r.l. and Fulbright scholar
The
accelerated pace of technology advancements is opening up new offerings in
personalized medicine, in biomarker training, in Invitro diagnostics. This
month we feature groundbreaking leaders to showcase advances and
opportunities in this market and touch upon cultural and moral dilemmas which
arise as these offerings gain traction.
Monday,
December 21
Holiday
Break
n/a
Below is a calendar for our 2008 life science entrepreneurs' forums, to take place in the evenings from 5:30 - 7:30 p.m.
Date
Title
Facilitator and Panelists
Tuesday, January 22
Life Science Angels Panel: Investment Trends in 08
Facilitator Aliki Helman, serial entrepreneur and former corporate exec
Panelist Stuart Eckmann, Keiretsu Forum and Life Science Angels (Bio and Device Committees)
Panelist Elaine Heron, Life Science Angels and LabCyte
Panelist Bob Molinari, MedStars
Panelist Don Ross, Life Science Angels and Sand Hill Angels
Tuesday, February 19
Incubating Life Science Companies
Facilitator Ted Spack, SRI International
Panelist Gayle Fagan, Managing Director, San Jose Biocenter
Panelist Jim Rurka, co-founder of Blanca Pharmaceuticals
Panelist Dave Yeomans, Trigemina Inc.
Monday, March 17
Partnering with Life Science Corporations
Facilitator Bruce W. Jenett, Partner, DLA Piper
Panelist Rob Abrams, Vice President New Business Development / New Ventures, Boston Scientific
Panelist Martin Doyle, Director of Mergers and Acquisitions, Applied Biosystems
Panelist Graeme R Martin Ph.D., Takeda Research Investment Inc
Panelist Ali Nasser, Director of Business Development, Roche Molecular Systems
Monday, April 21
Trends in Pharma
Facilitator Ted Spack, Senior Director of Business Development, SRI International
Panelist Dick Haiduck, Partner to the CEO of Implicit Bioscience and Cytopia
Panelist David Summa, CEO, Acumen Pharmaceuticals
Panelist Dr. Nicholas Saccomano, Senior Vice President of Worldwide Exploratory Science and Technology, Pfizer
Monday, May 19
Trends in the Medical Device Development
Facilitator Bruce W. Jenett, Partner, Co-Chair, Global Life Sciences Sector, DLA Piper US LLP
Rob Abrams, Operating Partner, Sanderling Ventures; former Vice President New Business Development/ New Ventures, Boston Scientific Corporation
Richard M. Ferrari, Managing Director, De Novo Ventures
William T. Harrington, MD, Partner, Three Arch Partners
Geetha Rao, Serial Medical Device Entrepreneur and Executive, Springborne Life Sciences and Triple Ring Technologies
Monday, June 16
Holiday Break
n/a
Monday, July 21
Holiday Break
n/a
Monday, August 18
Issues in Collaborative Development
Facilitator/moderator: Alan Schwartz-Ocio, Of Counsel, DLA Piper LLP Panelists: Adam Bristol, Investor, Biotechnology Value Fund
Jeff Jonker, Director of Business Development, Genentech
Jim I McLoughlin, Executive Director, Worldwide Business Development & Pfizer Venture Capital; Pfizer Inc. - Biotherapeutics and Bioinnovations Center
John Wulf, EVP & CBO, Trellis Bioscience
Monday, September 15
From Strategy to Execution: Growing Your Company to the Next Level
Facilitator Russell M. Singleton, Ph.D., President and CEO, Molecular Image, Inc.
Robert Abrams, Operating Partner, Sanderling Ventures
Bill Goure, Ph.D., COO, Acumen Pharmaceuticals
David Horwitz, M.D., Ph.D., World Wide Vice-President of Clinical Affairs and Evidence-Based Medicine, LifeScan
Ed Torres, Managing Director, Lilly Ventures
Monday, October 20
Show Me the Money: from Angels to Grants to VCs
Facilitator Geetha Rao, Springborne Life Sciences and Triple Ring Technologies
Panelist Adam S. Bristol, Ph.D., Biotechnology Value Fund, L.P.
Panelist Gino Di Sciullo, Ph.D., Charter Life Sciences
Panelist Dr. Evgeny Zaytsev, Partner, Asset Management Company
Panelist Allan W. May, Life Science Angels
Panelist Tom Rodgers, Principal, Advanced Technology Ventures
Monday, November 17
International Partnerships for Life Science Execs
Facilitator Simon Taylor, President, ACN Securities
Panelist Rinko Ghosh, Senior VP of Business Development and Alliance Management, Nektar Therapeutics
Panelist Phyllis Whiteley, PhD, Executive in Residence, Mohr Davidow Ventures
Panelist David Zarling, CEO, Colby Pharmaceutical Company
Other Panelists to be confirmed
Monday, December 15
Holiday Break
n/a
We are grateful to our partners and speakers for our 2007 programs and proudly acknowledge them below.
Date
Title
Facilitator
Tuesday, February 20
Corporate Investments in Life Science Companies
Facilitator Geetha Rao Panelist Linda Greub, Business Development, Applied Biosystems Panelist Eran Raber, Director, New Business and Venture Investments, Agilent Technologies Panelist Simon Greenwood, Ph.D., Senior Manager, Business Development, Genentech, Inc.
Monday, March 19
Positioning Your Life Science Company for Outside Funding
Facilitator Geetha Rao Panelist Brian Boyer, Perkins Coie LLP Panelist John Cornwell Life Science Angel Panelist Ken Martin, Onset Ventures Panelist David Miller Founder, InnoSpine
Monday, April 16
R&D Funding Opportunities
Facilitator Brian Boyer, Perkins Coie LLP Panelist Jeff Fairman, founder and senior research director, Juvaris Panelist Tom Gutshall, Founder and Former CEO, Current Chairman of Cepheid Panelist David Light, Business Builders
Tuesday, May 22
Trends in Life Science Investing
Facilitator Roy Fiebiger, Sanford Rose and Associates Panelist Andrew Farquharson, InCube Ventures Panelist Nina Kjellson, Partner, InterWest Partners Panelist John Maroney, General Partner, Delphi Ventures Panelist Kevin Wasserstein, Versant Ventures
Monday, June 18
Successful Entrepreneur Panel
Facilitator Roy Fiebiger, Sanford Rose and Associates Panelist Brent Contstantz, Skeletal Kinetics LLC Panelist Charlie Wen, Current founder and CTO, Tensegrity, former CEO of OrthoClear, Karegiver, former director of engineering and Align Technology Panelist Tony Zhang, PhD President, CEO and Chairman Formurex
Monday, July 16
Your Company's Value Proposition
Facilitator Sharon Lewis, President, Strategic Impact, Inc. Panelist – Valli Bindana, President & Creative Director, KreativeVistas Panelist – Ruth Cavagnaro, CEO, ChorusWare (Astia Portfolio Company) Panelist – Chisato Ishii, Investment Partner, JAIC America, Inc. Panelist – Ken Macrae, PhD, MD, EVP and Serial CEO Panelist – John Reed, Global Operations, Agilent Technologies Panelist - Fred Seddiqui, CEO, Avantis Medical Systems, Inc.
Monday, August 20
Outsourcing Options for Life Science Companies
Co-Facilitator Simon Goldbard, Ph.D., Corex Co-Facilitator Matt Perez, NearSoft Panelist Oren Beske, Ph.D., Director, Aragen Bioscience, Inc. Panelist Simon Greenwood, Senior Manager, Business Development, Genentech, Inc. Panelist Alshad S. Lalani, Ph.D., Director, Preclinical & Translational Oncology, Novacea, Inc. Panelist Angie You, COO Ren Pharmaceuticals
Monday, September 17
Navigating Government Regulations
Facilitators Linda Judge and Alan Schwartz Ocio from DLA Piper Panelist Anar Kotadia, MSS Consulting and Chair San Francisco Bay Area Chapter, Regulatory Affairs Professionals Society, formerly with Abbott, (with medical device perspective), RAPS Panelist Alan Jacobs, Acorn Biomedical (early stage clinical development) Panelist Geetha Rao (with a medical device perspective ) Panelist Rick Srigley, CEO & President of Aragen Bioscience
Monday, October 15
Marketing and Sales Operations for Life Science Entrepreneurs
Facilitator, Sharon Lewis, Founder and President, Strategic Impact, Inc. Panelist, Neelam Vaidya, Co-Founder and CEO, ChiroSolve Panelist, Rajiv Mehta, Co-Founder and CEO, Zume Life Panelist, Martin Babler, Entrepreneur, former VP Sales and Marketing Immunology, Genentech Inc. Panelist, Michael Mitchell, VP Marketing, Cantimer Panelist, Dan Galles, General Partner, HLM Venture Partners
Monday, November 19
Building An A+ Life Science Management Team
Facilitator Roy Fiebiger, Managing Partner, Sanford Rose Associates Panelist Chuck Brynelsen, CEO of IntraPace Panelist Dan Galles, General Partner, HLM Venture Partners Panelist Jonathan Goldman, MD., CMO Panelist Zack Scott, Director, Burrill & Company
Monday, December 17
Holiday Break
n/a
We are grateful to each of our 2006 facilitators and panelists for their participation and support and proudly acknowledge them below.
Date
Title
Facilitator
Monday, September 18
Life Sciences Entrepreneurs' Forum, Theme: Bringing the Product to Market
Melinda Richter, San Jose Bioscience Center Michael Shuster, Fenwick & West
Monday, October 16
Life Sciences Entrepreneurs' Forum Theme: Preparing for Outside Investors
Ken Macrae Geetha Rao Sergio Garcia
Monday, November 20
Life Sciences Entrepreneurs' Forum Theme: Building an A+ Life Science Management Team
Roy Fiebieger Tom Afzal, CEO of SpinalKinetics Andrew Farquharson, InCube Mike Hall, Latham & Watkins
Monday, December 18
Life Sciences Entrepreneurs' Forum: Holiday Break
n/a
FountainBlue's life sciences forums set themselves apart in that they address and connect multidisciplinary life sciences executives and investors.This is inclusive of, but not limited to medical devices, BioPharma, and emerging technologies such as wireless and nanotechnology applications in healthcare.We connect the companies' executives of various sizes that have different capabilities i.e. discovery vs. development to enhance relationships and foster productive discussions to promote common goals and expectations.
Sherri Dohemann, FountainBlue’s Chair and Director of Outreach for the Life Science Community
Join the FountainBlue community by completing the form below.
If you’re already a member, feel free to log in below.
